| Primary |
| Computerised Tomogram Abdomen |
29.3% |
| Computerised Tomogram |
27.3% |
| Arteriogram Coronary |
5.4% |
| Computerised Tomogram Thorax |
5.4% |
| Ct Scan |
4.4% |
| Computerised Tomogram Coronary Artery |
3.4% |
| Glioblastoma Multiforme |
3.4% |
| Premedication |
2.9% |
| Pneumonia |
2.4% |
| Urogram |
2.4% |
| Abdomen Scan |
2.0% |
| Scan With Contrast |
2.0% |
| Computerised Tomogram Head |
1.5% |
| Diagnostic Procedure |
1.5% |
| Hypertension |
1.5% |
| Imaging Procedure |
1.5% |
| Abdominal Cat |
1.0% |
| Abdominal Pain |
1.0% |
| Chest Pain |
1.0% |
| Computerized Tomogram Abdomen |
1.0% |
|
| Urticaria |
38.3% |
| Vomiting |
9.7% |
| Adverse Event |
4.6% |
| Dyspnoea |
4.6% |
| Pruritus |
4.0% |
| Sneezing |
4.0% |
| Tremor |
4.0% |
| Contrast Media Reaction |
3.4% |
| Loss Of Consciousness |
3.4% |
| Throat Irritation |
3.4% |
| Nausea |
2.9% |
| Rash |
2.9% |
| Renal Failure Acute |
2.9% |
| Muscle Contracture |
2.3% |
| Death |
1.7% |
| Swelling Face |
1.7% |
| Syncope |
1.7% |
| Throat Tightness |
1.7% |
| Unevaluable Event |
1.7% |
| Adverse Reaction |
1.1% |
|
| Secondary |
| Computerised Tomogram |
19.8% |
| Computerised Tomogram Abdomen |
13.7% |
| Product Used For Unknown Indication |
11.5% |
| Ct Scan |
6.9% |
| Premedication |
5.3% |
| Computerised Tomogram Coronary Artery |
4.6% |
| Computerised Tomogram Thorax |
4.6% |
| Lung Disorder |
4.6% |
| Status Epilepticus |
4.6% |
| Hypertension |
3.8% |
| Abdominal Pain |
3.1% |
| Glioblastoma Multiforme |
3.1% |
| Arteriogram Coronary |
2.3% |
| Chest Pain |
2.3% |
| Weight Decreased |
2.3% |
| Abdomen Scan |
1.5% |
| Abdominal Cat |
1.5% |
| Abdominal Exploration |
1.5% |
| Allergy Prophylaxis |
1.5% |
| Catheterisation Cardiac |
1.5% |
|
| Urticaria |
26.9% |
| Tremor |
11.5% |
| Vomiting |
7.7% |
| Contrast Media Reaction |
5.8% |
| Dyspnoea |
5.8% |
| Ear Pruritus |
3.8% |
| Muscle Spasms |
3.8% |
| Respiratory Distress |
3.8% |
| Restlessness |
3.8% |
| Throat Irritation |
3.8% |
| Thrombophlebitis Superficial |
3.8% |
| Wound Infection |
3.8% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
1.9% |
| Lung Disorder |
1.9% |
| Malaise |
1.9% |
| Nausea |
1.9% |
| Peritonitis |
1.9% |
| Product Quality Issue |
1.9% |
| Pruritus |
1.9% |
| Pruritus Generalised |
1.9% |
|
| Concomitant |
| Hepatic Neoplasm Malignant |
26.4% |
| Mri |
9.2% |
| Thyroid Cancer Stage Iv |
9.2% |
| Nuclear Magnetic Resonance Imaging |
8.0% |
| Haemorrhage Prophylaxis |
5.7% |
| Chronic Hepatitis C |
4.6% |
| Imaging Procedure |
4.6% |
| Abdominal Pain Upper |
3.4% |
| Angiogram |
3.4% |
| Bone Pain |
3.4% |
| Hypertension |
3.4% |
| Hypothyroidism |
3.4% |
| Thyroid Cancer |
3.4% |
| Bone Metastases |
2.3% |
| Breast Cancer |
2.3% |
| Hand And Foot Skin Reaction |
2.3% |
| Angiography |
1.1% |
| Blood Thyroid Stimulating Hormone Increased |
1.1% |
| Cardiovascular Event Prophylaxis |
1.1% |
| Ct Scan |
1.1% |
|
| Skin Tightness |
33.3% |
| Jaundice |
16.7% |
| Pulmonary Embolism |
16.7% |
| Pyrexia |
16.7% |
| Upper Gastrointestinal Haemorrhage |
16.7% |
|
